Volume 44, Issue 1 pp. 64-65
Full Access

Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat

KATSUMI YAMANAGA

KATSUMI YAMANAGA

Central Research Laboratory, Green Cross Corporation, Shodai-Ohtani 2-1180-1, Hirakata, Osaka 573, Japan

Search for more papers by this author
TAKESHI UCHIDA

Corresponding Author

TAKESHI UCHIDA

Central Research Laboratory, Green Cross Corporation, Shodai-Ohtani 2-1180-1, Hirakata, Osaka 573, Japan

Central Research Laboratory, Green Cross Corporation, 2-1180-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan.Search for more papers by this author
HIDEAKI KIDO

HIDEAKI KIDO

Central Research Laboratory, Green Cross Corporation, Shodai-Ohtani 2-1180-1, Hirakata, Osaka 573, Japan

Search for more papers by this author
KAZUTAKA HAYASHI

KAZUTAKA HAYASHI

Central Research Laboratory, Green Cross Corporation, Shodai-Ohtani 2-1180-1, Hirakata, Osaka 573, Japan

Search for more papers by this author
MASAHIRO WATANABE

MASAHIRO WATANABE

Central Research Laboratory, Green Cross Corporation, Shodai-Ohtani 2-1180-1, Hirakata, Osaka 573, Japan

Search for more papers by this author
First published: January 1992
Citations: 8

Abstract

Abstract— Repeated oral administration of the novel loop diuretic torasemide (3 mg kg−1) and frusemide (30 mg kg−1) for 7 days, elicited a significant fall in the systolic blood pressure in the one-kidney, one-clip Goldblatt renal hypertensive rat (RHR). The hypotensive action was greater in the torasemide group than in the frusemide group. Furthermore torasemide increased intracellular cAMP and cGMP content in aorta of RHR. Frusemide caused no effect. It is hypothesized that the increase in adenosine- or guanosine-nucleotides is involved in the antihypertensive action of torasemide, but not in that of frusemide.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.